Enzyme-linked immunosorbent spot (ELISpot) assays are one of the most sensitive cellular assays available, capable of detecting cytokine-secreting cells down to one cell in 100,000. Measuring the response of T cells to antigens is of vital importance in drug discovery and disease management. Although ELISpot assays employ the ELISA technique, they are up to 200 times more sensitive than conventional ELISA, and provide both qualitative and quantitative data. Spots can be counted using an automated system or can be done manually. Ready-to-use, one-step kits address the issues of assay complexity and reproducibility of data. These kits detect and enumerate one or two analytes simultaneously, thereby eliminating assay development and the need to purchase separate antibodies. For customized assays, development modules and components ensure flexibility.
The eBioscience IL-6 Ready-SET-Go! ELISA kit offers an easy and sensitive method...
Mouse IL-1beta ELISA MAX™ Standard Kit by BioLegend comes with many of the ...
Thursday, August 04, 2011
Cytokines are vital intercellular communication molecules. These proteins carry signals or messages when they ...
Friday, December 10, 2010
It is not surprising that cytokine analysis is a busy field – dysregulation of cytokines is known to lead to ...
Veronica Mankinen from Applied Biosystems provides an introduction to molecular techniques and their use for detecting dangerous pathogens such as Salmonella and Listeria monocytogenes in food.
Watch Video
Exiqon's microRNA qPCR system combines a Universal RT reaction with LNA™-enhanced PCR primers. Profile 742 microRNAs using just 40 ng total RNA on panels or quantify individual microRNAs from just 1 ...
Watch Video
Asuragen is a fully integrated pharmacogenomic services provider and diagnostic development and manufacturing company focused on RNA/miRNA biomarkers within oncology. This presentation describes ...
Watch Video
Monday, September 28, 2009
Local immunodiagnosis with a Mycobacterium tuberculosis (TB)–specific ELISpot (enzyme-linked immunospot) assay is useful for discriminating sputum AFB...
Inovio Pharmaceuticals, Inc. announced today that it has achieved strong T cell immune responses in a Phase I clinical study of PENNVAX®-B, its ...
ProImmune Ltd., a leader in services for understanding immune responses, has launched the B cell ELISpot assay as a service. The B cell ELISpot assay ...